Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Meng-Hang Yang"'
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundHistological transformation from non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is one of mechanisms of the acquired resistance to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI). However, SCLC
Externí odkaz:
https://doaj.org/article/443eab2ea75f4ca9b112a870a189286d
Autor:
Yu-Sheng Wang, Chao Zhou, Zheng-Wei Zhang, Xiao-Qian Shi, Xue-Wei Zhao, Yang Liu, Bing Li, Meng-Hang Yang
Background Lung adenocarcinoma (LUAD) is one of the most prevalent and lethal malignancies worldwide. Synaptotagmins (SYTs) are a group of transmembrane proteins of which dysregulation has been reported in various cancers. Here, we analyzed the role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2a85698077d0a3bbb22e62fcede5ef1
https://doi.org/10.21203/rs.3.rs-2792909/v1
https://doi.org/10.21203/rs.3.rs-2792909/v1
Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer, the leading cancer-related death worldwide. Nucleolar spindle-associated protein 1 (NUSAP1) is a microtubule-associated protein firstly been found in proliferating cells, and rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcc171ddfadc811689aea8e1bab67471
https://doi.org/10.21203/rs.3.rs-2792734/v1
https://doi.org/10.21203/rs.3.rs-2792734/v1
Publikováno v:
International Immunopharmacology. 117:109899
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b310cdf442921284507ab0656df7c18d
https://doi.org/10.1016/j.intimp.2023.109899
https://doi.org/10.1016/j.intimp.2023.109899
Publikováno v:
Current cancer drug targets. 22(10)
Background: Anti-angiogenesis therapy mostly aimed at targeting vascular endothelial growth factor (VEGF) and its receptors have been widely applied to lung cancer. However, the improvement in the patient's overall survival remains dissatisfying. Pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c3661b4a9af0fd998023f8059130b6d
https://pubmed.ncbi.nlm.nih.gov/35770414
https://pubmed.ncbi.nlm.nih.gov/35770414
Publikováno v:
2021 China Automation Congress (CAC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::999d7588530eca95ed0cdd149b4d8cd6
https://doi.org/10.1109/cac53003.2021.9727856
https://doi.org/10.1109/cac53003.2021.9727856
Publikováno v:
Molecular biology reports. 49(3)
Small cell lung cancer (SCLC) is the most malignant type of lung cancer. We previously reported that arsenic trioxide (AsTICs were enriched by culturing human SCLC cell line as sphere cells in specified serum-free medium. The expression of stem cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0184df161815b93c763a3a2463c17fdf
https://pubmed.ncbi.nlm.nih.gov/35028858
https://pubmed.ncbi.nlm.nih.gov/35028858
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Small cell lung cancer (SCLC) is the most deadly and aggressive type of primary lung cancer, with the 5-year survival rate lower than 5%. The FDA has approved arsenic trioxide (As(2)O(3)) for acute promyelocytic leukemia (APL) treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe9ac129597018ccb0ce1150db1b4fb0
https://pubmed.ncbi.nlm.nih.gov/32953511
https://pubmed.ncbi.nlm.nih.gov/32953511
Publikováno v:
Experimental and Therapeutic Medicine.
Gorham-Stout syndrome (GSS) is a rare disease characterized by spontaneous and progressive osteolysis caused by benign proliferation of lymphatic vessels or capillaries. It most commonly occurs in children or young individuals without any inherited p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::733a7109ae1466c7b1dcd7143c81fc90
https://doi.org/10.3892/etm.2020.8627
https://doi.org/10.3892/etm.2020.8627
Autor:
Meng-Hang Yang1, Ke-Jie Chang1, Jin-Cheng Zheng1, Hai Huang1, Guang-Yuan Sun2, Xue-Wei Zhao2, Bing Li1 bing_li1962@163.com, Qing-Yu Xiu1 xiu_qingyu@126.com
Publikováno v:
Oncology Letters. Sep2017, Vol. 14 Issue 3, p3103-3109. 7p.